SynthesisFrontiers in psychiatry2026
Effectiveness of vaping prevention campaign messages on cognitive and behaviorally proximal outcomes among adolescents and young adults: a systematic review and meta-analysis.
Synthesis in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vaping among adolescents has decreased but remains common among young adults, with ongoing concerns about nicotine health risks. Public health campaigns have increased vaping prevention messages, but evidence on their effectiveness, especially on cognitive and behavioral outcomes, is limited. Objective: This systematic review and meta-analysis aimed to synthesize recent experimental evidence on the effects of campaign-related vaping prevention messages on cognitive outcomes (e.g., knowledge, risk perception, perceived message effectiveness) and behaviorally proximal indicators (e.g., susceptibility to vaping and intentions to vape) among adolescents and young adults. Methods: A systematic search of five databases (Cochrane, PubMed, Scopus, CINAHL, and Web of Science) was conducted through January 2025. Thirteen Randomized Controlled Trials (RCTs) met the inclusion criteria, with six eligible for meta-analysis. The review adhered to PRISMA guidelines and was registered in PROSPERO ( CRD42025643032). The risk of bias was assessed using the RoB 2.0 tool. Meta-analyses were performed using a random-effects model to estimate pooled effect sizes. Results: The included studies (n=13) involved 11,235 participants aged 11-29 years. Most of the studies evaluated large-scale media campaigns or message-based interventions. Meta-analysis of six studies showed a statistically significant moderate effect on perceived vaping-related risk (Hedges' g = 0.254; 95% CI: 0.187-0.321), with zero heterogeneity (I² = 0.0%). Due to the small number of studies, publication bias testing was exploratory. For behaviorally proximal outcomes, subgroup analyses revealed a statistically significant protective effect on vaping susceptibility (g = -0.166; 95% CI: -0.256 to -0.076; I² = 0.0%), while effects on intentions to vape were non-significant and heterogeneous (g = -0.089; I² = 62.3%). Narrative synthesis indicated consistent improvements in knowledge, attitudes, and perceived message effectiveness, particularly for messages emphasizing health harms and chemical exposure. Conclusion: Campaign-related vaping prevention messages demonstrate consistent and robust effects on cognitive outcomes and susceptibility to vape, but yield heterogeneous and context-dependent effects on intentions. These findings underscore the importance of strategic message design and thematic framing while highlighting the need for longitudinal and population-level studies to determine whether cognitive shifts translate into sustained behavioral change. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42025643032, identifier CRD42025643032.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.